Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sarah Therrien, Adam Turnbull, Mia Anthony, Yeates Conwell & Feng Vankee Lin. (2023) Influence of affective states on informant impression of neuropsychiatric symptoms in people living with MCI. Aging & Mental Health 0:0, pages 1-6.
Read now
Read now
Stuart H Isaacson & Leslie Citrome. (2022) Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directions. Expert Opinion on Drug Safety 21:7, pages 873-879.
Read now
Read now
Shannon L. Webb, Damian P. Birney, Vanessa Loh, Sarah Walker, Amit Lampit & Alex Bahar-Fuchs. (2022) Cognition-oriented treatments for older adults: A systematic review of the influence of depression and self-efficacy individual differences factors. Neuropsychological Rehabilitation 32:6, pages 1193-1229.
Read now
Read now
Carol Dillon, Cecilia M Serrano, Diego Castro, Patricio Perez Leguizamón, Silvina L Heisecke & Fernando E Taragano. (2013) Behavioral symptoms related to cognitive impairment. Neuropsychiatric Disease and Treatment 9, pages 1443-1455.
Read now
Read now
Marcin Flirski, Monika Sieruta, Ewa Golanska, Iwona Kłoszewska, Paweł P. Liberski & Tomasz M. Sobow. (2012) PRND 3′UTR polymorphism may be associated with behavioral disturbances
in Alzheimer disease. Prion 6:1, pages 73-80.
Read now
Read now
Scott
E. Wilks, Kristina
G. Little, Heather
R. Gough & Wanda
J. Spurlock. (2011) Alzheimer's Aggression: Influences on Caregiver Coping and Resilience. Journal of Gerontological Social Work 54:3, pages 260-275.
Read now
Read now
Articles from other publishers (71)
Mervi Rantsi, Lauri Kortelainen, Virva Hyttinen, Johanna Jyrkkä & Eila Kankaanpää. (2023) Trends in the use of psychotropics in older people with dementia: interrupted time series of Finnish clinical guidelines of behavioural and psychological symptoms of dementia. Age and Ageing 52:6.
Crossref
Crossref
Ashlin R K Roy, Samir Datta, Emily Hardy, Virginia E Sturm, Joel H Kramer, William W Seeley, Katherine P Rankin, Howard J Rosen, Bruce L Miller & David C Perry. (2023) Behavioural subphenotypes and their anatomic correlates in neurodegenerative disease. Brain Communications 5:2.
Crossref
Crossref
Komanthi Kouloutbani, Fotini Venetsanou, Konstantinos E. Karteroliotis & Antonios Politis. (2023) Physical Exercise as a Nonpharmacological Intervention for the Treatment of Neuropsychiatric Symptoms in Persons With Dementia. Alzheimer Disease & Associated Disorders 37:1, pages 73-81.
Crossref
Crossref
Caitlyn J. Bartsch & Jacob C. Nordman. (2022) Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression. Frontiers in Behavioral Neuroscience 16.
Crossref
Crossref
Kimberly R. Chapman & Mary Beth Spitznagel. (2022) The need for disinhibition-focused interventions in dementia. International Psychogeriatrics 34:4, pages 331-334.
Crossref
Crossref
Gerald J. Jogerst. (2021) Evaluation of early non-cognitive markers of dementia. Russian Family Doctor 25:4, pages 7-14.
Crossref
Crossref
Yuan Shao, Haiyun Xu, Jian Wang, Xijian Dai, Wei Liang, Lina Ren & Yongjun Wang. (2021) Agitation and apathy increase risk of dementia in psychiatric inpatients with late-onset psychiatric symptoms. BMC Psychiatry 21:1.
Crossref
Crossref
Jayne E. Kelleher, Peter Weedle & Maria D. Donovan. (2021) The Prevalence of and Documented Indications for Antipsychotic Prescribing in Irish Nursing Homes. Pharmacy 9:4, pages 160.
Crossref
Crossref
Kimberly R. Chapman, Geoffrey Tremont & Mary Beth Spitznagel. (2021) Development of an assessment measure for sexual disinhibition in dementia. International Journal of Geriatric Psychiatry 36:9, pages 1436-1449.
Crossref
Crossref
Sheng-Min Wang, Kyung-do Han, Nak-Young Kim, Yoo Hyun Um, Dong-Woo Kang, Hae-Ran Na, Chang-Uk Lee & Hyun Kook Lim. (2021) Late-life depression, subjective cognitive decline, and their additive risk in incidence of dementia: A nationwide longitudinal study. PLOS ONE 16:7, pages e0254639.
Crossref
Crossref
Stuart H. Isaacson, Clive G. Ballard, David L. Kreitzman, Bruce Coate, James C. Norton, Hubert H. Fernandez, Tihomir V. Ilic, Jean-Philippe Azulay, Joaquim J. Ferreira, Victor Abler & Srdjan Stankovic. (2021) Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients. Parkinsonism & Related Disorders 87, pages 25-31.
Crossref
Crossref
Stephen Macfarlane, Mustafa Atee, Thomas Morris, Daniel Whiting, Madeleine Healy, Marie Alford & Colm Cunningham. (2021) Evaluating the Clinical Impact of National Dementia Behaviour Support Programs on Neuropsychiatric Outcomes in Australia. Frontiers in Psychiatry 12.
Crossref
Crossref
Shuyi Wu & Rongjun Yu. 2021. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging
611
616
.
Clive G. Ballard, David L. Kreitzman, Stuart Isaacson, I-Yuan Liu, James C. Norton, George Demos, Hubert H. Fernandez, Tihomir V. Ilic, Jean-Philippe Azulay, Joaquim J. Ferreira, Victor Abler & Srdjan Stankovic. (2020) Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis. Parkinsonism & Related Disorders 77, pages 100-106.
Crossref
Crossref
Sascha Gill, Pauline Mouches, Sophie Hu, Deepthi Rajashekar, Frank P. MacMaster, Eric E. Smith, Nils D. Forkert & Zahinoor Ismail. (2020) Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data. Journal of Alzheimer's Disease 75:1, pages 277-288.
Crossref
Crossref
Sabela C. Mallo, Scott B. Patten, Zahinoor Ismail, Arturo X. Pereiro, David Facal, Carlos Otero & Onésimo Juncos-Rabadán. (2020) Does the neuropsychiatric inventory predict progression from mild cognitive impairment to dementia? A systematic review and meta-analysis. Ageing Research Reviews 58, pages 101004.
Crossref
Crossref
Shuyi Wu & Rongjun Yu. 2020. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging
1
6
.
Manuel Montero‐Odasso, Frederico Pieruccini‐Faria, Zahinoor Ismail, Karen Li, Andrew Lim, Natalie Phillips, Nellie Kamkar, Yanina Sarquis‐Adamson, Mark Speechley, Olga Theou, Joe Verghese, Lindsay Wallace & Richard Camicioli. (2020) CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus. Alzheimer's & Dementia: Translational Research & Clinical Interventions 6:1.
Crossref
Crossref
P. Nordström & A. Nordström. (2019) Use of short-acting and long-acting hypnotics and the risk of fracture: a critical analysis of associations in a nationwide cohort. Osteoporosis International 30:10, pages 1983-1993.
Crossref
Crossref
Tim Fleiner, Marleen Gersie, Sayantan Ghosh, Sabato Mellone, Wiebren Zijlstra & Peter Haussermann. (2018) Prominent physical inactivity in acute dementia care: Psychopathology seems to be more important than the dose of sedative medication. International Journal of Geriatric Psychiatry 34:2, pages 308-314.
Crossref
Crossref
Katharina Allers, Michael Dörks, Guido Schmiemann & Falk Hoffmann. (2017) Antipsychotic drug use in nursing home residents with and without dementia. International Clinical Psychopharmacology 32:4, pages 213-218.
Crossref
Crossref
Alice Breining, Dominique Bonnet-Zamponi, Lorène Zerah, Carole Micheneau, Nathalie Riolacci-Dhoyen, Christine Chan-Chee, Jean Deligne, Jean-Marc Harlin, Jacques Boddaert, Marc Verny & Armelle Leperre-Desplanques. (2017) Exposure to psychotropics in the French older population living with dementia: a nationwide population-based study. International Journal of Geriatric Psychiatry 32:7, pages 750-760.
Crossref
Crossref
Wei‐Chen Lin, Li‐Yu Hu, Shih‐Jen Tsai, Albert C. Yang & Cheng‐Che Shen. (2016) Depression and the risk of vascular dementia: a population‐based retrospective cohort study. International Journal of Geriatric Psychiatry 32:5, pages 556-563.
Crossref
Crossref
Ting-Jung Hsu, Hui-Te Tsai, An-Chun Hwang, Liang-Yu Chen & Liang-Kung Chen. (2017) Predictors of non-pharmacological intervention effect on cognitive function and behavioral and psychological symptoms of older people with dementia. Geriatrics & Gerontology International 17, pages 28-35.
Crossref
Crossref
Michele Torrisi, Maria C. De Cola, Angela Marra, Rosaria De Luca, Placido Bramanti & Rocco S. Calabrò. (2017) Neuropsychiatric symptoms in dementia may predict caregiver burden: a Sicilian exploratory study. Psychogeriatrics 17:2, pages 103-107.
Crossref
Crossref
Gerard Esteban, Jolien Van Schoors, Ping Sun, Ann Van Eeckhaut, José Marco-Contelles, Ilse Smolders & Mercedes Unzeta. (2017)
In-vitro
and
in-vivo
evaluation of the modulatory effects of the multitarget compound ASS234 on the monoaminergic system
. Journal of Pharmacy and Pharmacology 69:3, pages 314-324.
Crossref
Crossref
Zahinoor Ismail, Luis Agüera-Ortiz, Henry Brodaty, Alicja Cieslak, Jeffrey Cummings, Corinne E. Fischer, Serge Gauthier, Yonas E. Geda, Nathan Herrmann, Jamila Kanji, Krista L. Lanctôt, David S. Miller, Moyra E. Mortby, Chiadi U. Onyike, Paul B. Rosenberg, Eric E. Smith, Gwenn S. Smith, David L. Sultzer & Constantine Lyketsos. (2017) The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations. Journal of Alzheimer's Disease 56:3, pages 929-938.
Crossref
Crossref
Bruno Franchi. (2016) Pharmacological management of behavioural and psychological symptoms of dementia. Journal of Pharmacy Practice and Research 46:3, pages 277-285.
Crossref
Crossref
Chen Ling, Dai Fangyu, Hu Wanhua, Chen Kelong, Wu zhimin, Zhang yuting & Zhou rong. (2015) DNMT3A rs1550117 Polymorphism is Associated With Late-Onset Alzheimer’s Disease in a Chinese Population. American Journal of Alzheimer's Disease & Other Dementiasr 31:3, pages 278-281.
Crossref
Crossref
Kazuyo YoshiyamaHideko AritaJinichi Suzuki. (2015) The Effect of Aroma Hand Massage Therapy for People with Dementia. The Journal of Alternative and Complementary Medicine 21:12, pages 759-765.
Crossref
Crossref
Filippo Caraci, Giuseppe Pappalardo, Livia Basile, Alessandro Giuffrida, Agata Copani, Rita Tosto, Alessandro Sinopoli, Maria Laura Giuffrida, Emanuele Pirrone, Filippo Drago, Rosario Pignatello & Salvatore Guccione. (2015) Neuroprotective effects of the monoamine oxidase inhibitor tranylcypromine and its amide derivatives against Aβ(1–42)-induced toxicity. European Journal of Pharmacology 764, pages 256-263.
Crossref
Crossref
S.-M. Paddick, A. Kisoli, A. Longdon, C. Dotchin, W. K. Gray, P. Chaote, A. Teodorczuk & R. Walker. (2015) The prevalence and burden of behavioural and psychological symptoms of dementia in rural Tanzania. International Journal of Geriatric Psychiatry 30:8, pages 815-823.
Crossref
Crossref
Jennifer Tjia, Terry Field, Kathleen Mazor, Celeste A. Lemay, Abir O. Kanaan, Jennifer L. Donovan, Becky A. Briesacher, Daniel Peterson, Michelle Pandolfi, Ann Spenard & Jerry H. Gurwitz. (2015) Dissemination of Evidence-Based Antipsychotic Prescribing Guidelines to Nursing Homes: A Cluster Randomized Trial. Journal of the American Geriatrics Society 63:7, pages 1289-1298.
Crossref
Crossref
Graham McIlroy, Sarah K. Thomas & Jamie J. Coleman. (2015) Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing. Journal of Public Health 37:2, pages 346-352.
Crossref
Crossref
A.-J. Bianchi, H. Gu?pet-Sordet & P. Manckoundia. (2015) Modifications de l?olfaction au cours du vieillissement et de certaines pathologies neurod?g?n?ratives?: mise au point. La Revue de M?decine Interne 36:1, pages 31-37.
Crossref
Crossref
Andrew H. Ford. (2014) Neuropsychiatric aspects of dementia. Maturitas 79:2, pages 209-215.
Crossref
Crossref
A. Corbett, B. S. Husebo, W. P. Achterberg, D. Aarsland, A. Erdal & E. Flo. (2014) The importance of pain management in older people with dementia. British Medical Bulletin 111:1, pages 139-148.
Crossref
Crossref
Bettina S. Husebo, Clive Ballard, Jiska Cohen-Mansfield, Reinhard Seifert & Dag Aarsland. (2014) The Response of Agitated Behavior to Pain Management in Persons with Dementia. The American Journal of Geriatric Psychiatry 22:7, pages 708-717.
Crossref
Crossref
Mehdi Farokhnia, Mehdi Shafiee Sabet, Negar Iranpour, Amirhossein Gougol, Habibeh Yekehtaz, Roozbeh Alimardani, Farzaneh Farsad, Maryam Kamalipour & Shahin Akhondzadeh. (2014)
Comparing the efficacy and safety of
Crocus sativus
L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
. Human Psychopharmacology: Clinical and Experimental 29:4, pages 351-359.
Crossref
Crossref
Victor Bloniecki, Dag Aarsland, Jeffrey Cummings, Kaj Blennow & Yvonne Freund-Levi. (2014) Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels. Dementia and Geriatric Cognitive Disorders Extra 4:2, pages 335-343.
Crossref
Crossref
Rue-Chuan Chen, Chien-Liang Liu, Ming-Hsien Lin, Li-Ning Peng, Liang-Yu Chen, Li-Kuo Liu & Liang-Kung Chen. (2014) Non-pharmacological treatment reducing not only behavioral symptoms, but also psychotic symptoms of older adults with dementia: A prospective cohort study in Taiwan. Geriatrics & Gerontology International 14:2, pages 440-446.
Crossref
Crossref
Shuying Zhang, Helen Edwards, Patsy Yates, Qihao Guo & Chunbo Li. (2013) Partial Mediation Role of Self-Efficacy between Positive Social Interaction and Mental Health in Family Caregivers for Dementia Patients in Shanghai. PLoS ONE 8:12, pages e83326.
Crossref
Crossref
Celeste A. Lemay, Kathleen M. Mazor, Terry S. Field, Jennifer Donovan, Abir Kanaan, Becky A. Briesacher, Sarah Foy, Leslie R. Harrold, Jerry H. Gurwitz & Jennifer Tjia. (2013) Knowledge of and Perceived Need for Evidence-Based Education About Antipsychotic Medications Among Nursing Home Leadership and Staff. Journal of the American Medical Directors Association 14:12, pages 895-900.
Crossref
Crossref
Jana Schulze, Gerd Glaeske, Hendrik van den Bussche, Hanna Kaduszkiewicz, Daniela Koller, Birgitt Wiese & Falk Hoffmann. (2013) Prescribing of antipsychotic drugs in patients with dementia: a comparison with age‐matched and sex‐matched non‐demented controls. Pharmacoepidemiology and Drug Safety 22:12, pages 1308-1316.
Crossref
Crossref
Berit Johannessen. (2013) Nurses experience of aromatherapy use with dementia patients experiencing disturbed sleep patterns. An action research project. Complementary Therapies in Clinical Practice 19:4, pages 209-213.
Crossref
Crossref
Jana Schulze, Hendrik van den Bussche, Gerd Glaeske, Hanna Kaduszkiewicz, Birgitt Wiese & Falk Hoffmann. (2013) Impact of safety warnings on antipsychotic prescriptions in dementia: Nothing has changed but the years and the substances. European Neuropsychopharmacology 23:9, pages 1034-1042.
Crossref
Crossref
Irene Bolea, Alejandro Gella & Mercedes Unzeta. (2012) Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors. Journal of Neural Transmission 120:6, pages 893-902.
Crossref
Crossref
Julia van de Ven‐Vakhteeva, Hans Bor, Roland B. Wetzels, Raymond T. C. M. Koopmans & Sytse U. Zuidema. (2012) The impact of antipsychotics and neuropsychiatric symptoms on the quality of life of people with dementia living in nursing homes. International Journal of Geriatric Psychiatry 28:5, pages 530-538.
Crossref
Crossref
Jean Lachaine, Catherine Beauchemin, Anne Crochard & Sébastien Bineau. (2013) The Impact of Memantine and Cholinesterase Inhibitor Initiation for Alzheimer Disease on the Use of Antipsychotic Agents: Analysis Using the Régie de l'Assurance Maladie du Québec Database. The Canadian Journal of Psychiatry 58:4, pages 195-200.
Crossref
Crossref
Eva Mann, Burkhard Haastert, Birgit Böhmdorfer, Thomas Frühwald, Bernhard Iglseder, Regina Roller-Wirnsberger & Gabriele Meyer. (2013) Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional studyPrävalenz und Assoziationen von potentiell unangemessenen Verordnungen bei österreichischen Pflegeheimbewohnern: Sekundäranalyse einer Querschnittsstudie. Wiener klinische Wochenschrift 125:7-8, pages 180-188.
Crossref
Crossref
Secundino López-Pousa, Oriol Turró-Garriga, Laia Calvó-Perxas, Olga Carmona, Jordi Gich, Elisabet Alsina, Fabià Màrquez, Marta Viñas, Josefa Turbau, Joan Vilalta-Franch, Anna Maria Roig & Josep Garre-Olmo. (2012) Consumption of Pharmaceuticals in Primary Non-Alzheimer’s Degenerative Dementias. Drugs & Aging 29:9, pages 733-740.
Crossref
Crossref
Salvatore Salomone, Filippo Caraci, Gian Marco Leggio, Julia Fedotova & Filippo Drago. (2012) New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. British Journal of Clinical Pharmacology 73:4, pages 504-517.
Crossref
Crossref
Filippo Caraci, Simona Spampinato, Maria Angela Sortino, Paolo Bosco, Giuseppe Battaglia, Valeria Bruno, Filippo Drago, Ferdinando Nicoletti & Agata Copani. (2011) Dysfunction of TGF-?1 signaling in Alzheimer?s disease: perspectives for neuroprotection. Cell and Tissue Research 347:1, pages 291-301.
Crossref
Crossref
Linda Nazarko. (2011) Tackling ‘Sundowning’ in Dementia Care. British Journal of Healthcare Assistants 5:11, pages 544-547.
Crossref
Crossref
B.S. Husebo, C. Ballard & D. Aarsland. (2011) Pain treatment of agitation in patients with dementia: a systematic review. International Journal of Geriatric Psychiatry 26:10, pages 1012-1018.
Crossref
Crossref
René Padilla. (2011) Effectiveness of Environment-Based Interventions for People With Alzheimer’s Disease and Related Dementias. The American Journal of Occupational Therapy 65:5, pages 514-522.
Crossref
Crossref
Kristina G. Little & Scott E. Wilks. (2011) Psychometric Evaluation of a Proposed Alzheimer’s Aggression Scale. American Journal of Alzheimer's Disease & Other Dementiasr 26:5, pages 373-380.
Crossref
Crossref
John W. BidewellEsther Chang. (2011) Managing dementia agitation in residential aged care. Dementia 10:3, pages 299-315.
Crossref
Crossref
Filippo Caraci, Giuseppe Battaglia, Valeria Bruno, Paolo Bosco, Viviana Carbonaro, Maria Laura Giuffrida, Filippo Drago, Maria Angela Sortino, Ferdinando Nicoletti & Agata Copani. (2011) TGF-?1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease. CNS Neuroscience & Therapeutics 17:4, pages 237-249.
Crossref
Crossref
Rianne van der Linde, Blossom CM Stephan, Fiona E Matthews, Carol Brayne & George M Savva. (2010) Behavioural and psychological symptoms in the older population without dementia - relationship with socio-demographics, health and cognition. BMC Geriatrics 10:1.
Crossref
Crossref
Annie Prado‐Jean, Philippe Couratier, Michel Druet‐Cabanac, Philippe Nubukpo, Laurence Bernard‐Bourzeix, Philippe Thomas, Nicole Dechamps, Helene Videaud, Thierry Dantoine & Jean Pierre Clément. (2010) Specific psychological and behavioral symptoms of depression in patients with dementia. International Journal of Geriatric Psychiatry 25:10, pages 1065-1072.
Crossref
Crossref
K. de Medeiros, P. Robert, S. Gauthier, F. Stella, A. Politis, J. Leoutsakos, F. Taragano, J. Kremer, A. Brugnolo, A. P. Porsteinsson, Y. E. Geda, H. Brodaty, G. Gazdag, J. Cummings & C. Lyketsos. (2010) The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. International Psychogeriatrics 22:6, pages 984-994.
Crossref
Crossref
Tor Atle Rosness, Maria Lage Barca & Knut Engedal. (2010) Occurrence of depression and its correlates in early onset dementia patients. International Journal of Geriatric Psychiatry 25:7, pages 704-711.
Crossref
Crossref
Debra R. Kahn, Raheel A. Khan & James A. Bourgeois. 2010. Psychosomatic Medicine. Psychosomatic Medicine
89
99
.
Fozia Roked, Asha Omar, Fayaz Roked, Ridwan Ahmed & Abdul Patel. (2010) Antipsychotics in dementia: are they being appropriately prescribed?. International Psychogeriatrics 22:3, pages 501-502.
Crossref
Crossref
Bei Hu, Leslie Ross, John Neuhaus, David Knopman, Joel Kramer, Bradley Boeve, Richard J. Caselli, Neill Graff-Radford, Mario F. Mendez, Bruce L. Miller & Adam L. Boxer. (2010) Off-Label Medication Use in Frontotemporal Dementia. American Journal of Alzheimer's Disease & Other Dementiasr 25:2, pages 128-133.
Crossref
Crossref
Filippo Caraci, Agata Copani, Ferdinando Nicoletti & Filippo Drago. (2010) Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets. European Journal of Pharmacology 626:1, pages 64-71.
Crossref
Crossref
Antony Bayer. 2010. Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Brocklehurst's Textbook of Geriatric Medicine and Gerontology
392
401
.
Susanne Nikolaus, Christina Antke & Hans-Wilhelm Müller. (2009) In vivo imaging of synaptic function in the central nervous system. Behavioural Brain Research 204:1, pages 1-31.
Crossref
Crossref
Amos D. Korczyn & Ilan Halperin. (2009) Depression and dementia. Journal of the Neurological Sciences 283:1-2, pages 139-142.
Crossref
Crossref
Dirk K. Wolter. (2009) Risiken von Antipsychotika im Alter, speziell bei Demenzen 1Prof. Dr. Hans Gutzmann zum 60. Geburtstag gewidmet.. Zeitschrift für Gerontopsychologie & -psychiatrie 22:1, pages 17-56.
Crossref
Crossref